AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 173 filers reported holding AURINIA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $422,711 | -86.4% | 54,403 | -83.0% | 0.01% | -86.4% |
| Q2 2023 | $3,097,774 | +52.4% | 320,018 | +72.6% | 0.08% | +44.6% |
| Q1 2023 | $2,032,444 | +380.9% | 185,442 | +89.6% | 0.06% | +366.7% |
| Q4 2022 | $422,600 | -45.4% | 97,824 | -5.0% | 0.01% | -55.6% |
| Q3 2022 | $774,000 | +75.5% | 102,932 | +134.6% | 0.03% | +35.0% |
| Q2 2022 | $441,000 | -9.1% | 43,871 | +106.8% | 0.02% | -33.3% |
| Q4 2021 | $485,000 | +44.3% | 21,210 | -18.3% | 0.03% | +7.1% |
| Q2 2021 | $336,000 | -27.4% | 25,960 | -27.2% | 0.03% | -33.3% |
| Q1 2021 | $463,000 | +64.8% | 35,648 | +86.8% | 0.04% | +133.3% |
| Q3 2020 | $281,000 | -79.1% | 19,081 | -71.2% | 0.02% | -77.2% |
| Q4 2019 | $1,343,000 | – | 66,304 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 503,248 | $6,535,000 | 10.30% |
| Prosight Management, LP | 360,834 | $4,685,000 | 3.84% |
| Healthcare Value Capital, LLC | 100,000 | $1,299,000 | 2.89% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,748,208 | $22,700,000 | 2.32% |
| DG Capital Management, LLC | 591,154 | $7,676,000 | 1.83% |
| NEA Management Company, LLC | 5,172,683 | $67,193,000 | 1.51% |
| Altium Capital Management LP | 408,908 | $5,310,000 | 1.47% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 170,316 | $2,212,000 | 1.17% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 298,500 | $3,875,000 | 1.02% |
| KNOTT DAVID M | 154,840 | $2,011,000 | 0.86% |